latest update:
[TrialBase DB]

trial summary · NCT07148843

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

Trial record from the TrialBase DB dataset, status RECRUITING, condition Alcohol Use Disorder (AUD), sponsored by Johns Hopkins University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07148843phase PHASE2/PHASE3enrollment 105start 2026-11-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Cannabidiol (CBD), one of the most prevalent cannabinoids in cannabis (marijuana) has been shown to reduce alcohol withdrawal symptoms in laboratory animals. In people without alcohol use disorder (AUD), CBD has been show to be effective in reducing anxiety, sleep problems, and seizures; all of these are common symptoms of alcohol withdrawal. This randomized placebo-controlled clinical trial will evaluate the potential of CBD to improve alcohol withdrawal symptoms and reduce craving during acute abstinence among individuals with moderate-to-severe AUD. Adult participants with moderate-to-severe AUD will be admitted to an inpatient research unit at the Johns Hopkins Hospital for a 5-day, 4-night stay that includes alcohol abstinence with management of their alcohol withdrawal. In addition to standard care, participants will receive CBD or placebo (no CBD), complete assessments of withdrawal, sleep quality and provide breath and blood samples.

Source record: https://clinicaltrials.gov/study/NCT07148843

Facts

registry idNCT07148843
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2/PHASE3
study typeINTERVENTIONAL
lead conditionAlcohol Use Disorder (AUD)
sponsorJohns Hopkins University
sponsor classOTHER
enrollment105
start date2026-11-01
primary completion2030-10-31
completion2030-10-31
results postednot reported

Conditions

  • Alcohol Use Disorder (AUD)
  • Withdrawal From Addictive Substance; Detoxification
  • Craving

Interventions

  • Cannabidiol (CBD)
  • Placebo

Countries

  • United States

Intervention types: DRUG

Work with this record